🇺🇸 FDA
Pipeline program

ETC-159

ETC-159-02

Phase 1 small_molecule active

Quick answer

ETC-159 for With MSS/pMMR Advanced, Platinum-resistant Ovarian Cancer is a Phase 1 program (small_molecule) at BRIGHT MINDS BIOSCIENCES INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
BRIGHT MINDS BIOSCIENCES INC.
Indication
With MSS/pMMR Advanced, Platinum-resistant Ovarian Cancer
Phase
Phase 1
Modality
small_molecule
Status
active

Clinical trials